Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension

Journal of Hypertension

Volumn 15, Issue 1, 1997, Pages 57-63

  Schiffrin, Ernesto L ^a   Deng, Li Yuan ^a   Sventek, Pavol ^a   Day, Robert ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Endothelin receptors; Small arteries; Vascular hypertrophy; Vascular remodeling

Indexed keywords

ENDOTHELIN 1; MESSENGER RNA;

ADULT; ARTERY; ARTICLE; BIOPSY; CLINICAL ARTICLE; ESSENTIAL HYPERTENSION; GENE EXPRESSION; GLUTEUS MAXIMUS MUSCLE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; SUBCUTANEOUS FAT;

EID: 0031045954     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715010-00005     Document Type: Article

References (37)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
2. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990, 258:C408-C415.
3. Hirata Y, Takagi Y, Fukuda Y, Marumo F: Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989, 78:225-228.
4. Schiffers PWH, Fazzi GE, Van Ingen Schenau D, De Mey JGR: Effects of candidate autocrine and paracrine mediators on growth responses in isolated rat arteries. Arterioscler Thromb 1994, 14:420-426.
5. Schiffrin EL: Endothelin, potential role in hypertension and vascular hypertrophy. Brief review. Hypertension 1995, 25:1135-1143.
6. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, et al.: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992, 267:16066-16068.
7. Larivirèe R, Thibault G, Schiffrin EL: Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993, 21:294-300.
8. Larivirèe R, Day R, Schiffrin EL: Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1993, 21:916-920.
9. Day R, Larivirèe R, Schiffrin EL: In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 1995, 8:294-300.
10. Larivirèe R, Deng LY, Day R, Sventek P, Thibault G, Schiffrin EL: Increased endothelin-1 gene expression in the endothelium of coronary arteries and in the endocardium of DOCA-salt hypertensive rats. J Mol Cell Cardiol 1995, 27:2123-2131.
11. Schiffrin EL, Larivirèe R, Li J-S, Sventek P, Touyz RM: Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 1995, 25:769-773.
12. Li JS, Larivirèe R, Schiffrin EL: Effect of a non selective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Hypertension 1994, 24:183-188.
13. Schiffrin EL, Sventek P, Li J-S, Turgeon A, Reudelhuber T: Antihypertensive effect of bosentan, a mixed ETA/ETB endothelin receptor antagonist, in DOCA-salt spontaneously hypertensive rats. Br J Pharmacol 1995, 115:1377-1381.
14. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, et al: A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990, 78:261-264.
15. Schiffrin EL, Thibault G: Plasma endothelin in human essential hypertension. Am J Hypertens 1991, 4:303-308.
16. Haynes WG, Webb DJ: Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994, 344:852-854.
17. Wenzel RR, Noll G, Lüscher TF: Endothelin receptor antagonists inhibit endothelin in human skin microcirculation. Hypertension 1994, 23:581-586.
18. Schiffrin EL, Deng LY, Larochelle P: Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993, 16:177-186.
19. Schiffrin EL, Deng LY, Larochelle P: Effects of a beta blocker or converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994, 23:83-91.
20. Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta blocker. Am J Hypertens 1995, 8:229-236.
21. Bloch KD, Friederich SP, Lee ME, Eddy RL, Shows TB, Quertermous T: Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem 1989, 264:10851-10857.
22. Schiffrin EL, Larivirèe R, Li J-S, Sventek P: Enhanced expression of endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res 1996, 33:235-248.
23. Li JS, Schürch W, Schiffrin EL: Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. Am J Hypertens 1996, 9:803-811.
24. Li J-S, Deng LY, Grove K, Deschepper CF, Schiffrin EL: Comparison of endothelin antagonism and angiotensin converting enzyme inhibition on blood pressure and vascular structure in L-NAME-treated spontaneously hypertensive rats. Hypertension 1996, 28:188-195.
25. Li J-S, Knafo L, Turgeon A, Garcia R, Schiffrin EL: Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats. Am J Physiol 1996, 40:H88-H93.
26. Sventek P, Turgeon A, Garcia R, Schiffrin EL: Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney, one clip Goldblatt hypertension. J Hypertens 1996, 14:57-64.
27. Mulvany MJ, Aalkjær C: Structure and function of small arteries. Physiol Rev 1990, 70:921-971.
28. Stasch J-P, Hirth-Dietrich C, Frobel K, Wegner M: Prolonged endothelin blockade prevents hypertension and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Am J Hypertens 1995, 8:1128-1134.
29. Vanhoutte PM: Is endothelin involved in the pathogenesis of hypertension? Hypertension 1993, 21:747-751.
30. Lüscher TF, Seo B, Bühler FR: Potential role of endothelin in hypertension. Hypertension 1993, 21:752-757.
31. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T: Pressure enhances endothelin-1 release from cultured human endothelial cells. Hypertension 1995, 25:449-452.
32. de Nucci G, Thomas R, D'Orléans-Juste P, Antunes E, Walder C, Warner TD, et al.: Pressor effects of circulating endothelin are limited by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1989, 85:9797-9800.
33. Deng LY, Li J-S, Schiffrin EL: Endothelin receptor subtypes in resistance arteries from humans and from rats. Cardiovasc Res 1995, 29:532-535.
34. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, et al.: Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989, 161:859-864.
35. Malek A, Izumo S: Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium. Am J Physiol 1992, 263:C389-C396.
36. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, et al.: Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989, 159:1435-1440.
37. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F: Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992, 19:753-757.